Catalyst Wire Dossier Catalyst Wire Dossier

TolaSure

· BioMendics, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TolaSure, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex [Phase 2]

See pricing